Each of the three Research Projects proposed by the Uganda-UCSF Consortium on Prevention and Early Detection of HIV-associated Cancer involves prospective field-based data collection. Each also features the need for biostatistical analysis. Because the Consortium recognizes the importance of data management and biostatistical analysis to research and wishes to transfer relevant technology and approaches to Africa, it will create one shared and efficient resource core for these purposes. The Data Management and Biostatistical Analysis Core (DMBAC) of the Uganda-UCSF Consortium will have the following specific aims:
Aim 1. Provide expertise and a common platform for primary data collection and data management. The DMBAC will leverage the expertise in data management built at the Department of Epidemiology and Biostatistics at UCSF over the past two decades and transfer it to the Infectious Diseases Institute (IDI) in Uganda for the support of our three Research Projects and any pilot projects funded by the Consortium.
Aim 2. Offer project-specific biostatistical support both during the planning of new research and during the analysis of ongoing studies as well as specialized biostatistical instruction to our emerging Ugandan principal investigators. By offering assistance from faculty-level biostatisticians who are familiar with the substantive aspects of HIV-associated malignancies, the DMBAC will ensure that the 3 Research Projects and any relevant pilot projects are designed and analyzed using the most appropriate biostatistical strategies. Periodic didactic instruction in specialized analytical techniques will allow the emerging Ugandan scientists to keep abreast with current methods and be conversant with biostatisticians. At the end of the 5-year funding period, the DMBAC will have provided support in data management and biostatistical analysis to each of the three Research Projects and all pilot projects that are borne from the consortium. It will have also transferred relevant technology and skills from specialists at UCSF to colleagues in Uganda. Finally, and equally important, it will have also given the emerging Ugandan principal investigators a critical opportunity to interact with and form professional relationships with some of their most important allies data managers and biostatisticians. These relationships and the best practices derived from them will give the emerging Uganda scientists the solid foundation they need for rest of their career.

Public Health Relevance

This project is bringing together scientists from both the University of California, San Francisco (UCSF) and Uganda to study cancer and HIV infection in sub-Saharan Africa. These scientists will need to collect large amounts of data, keep it organized, and then analyze it with statistics. To achieve this, we will make available to them a central group of experts in the management of data and in the statistical analysis of data.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
1U54CA190153-01
Application #
8933037
Study Section
Special Emphasis Panel (ZCA1-RPRB-O (M2))
Program Officer
Dominguez, Geraldina
Project Start
2014-09-17
Project End
2019-08-31
Budget Start
2014-09-17
Budget End
2015-08-31
Support Year
1
Fiscal Year
2014
Total Cost
$52,967
Indirect Cost
$8,400
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Amerson, Erin; Woodruff, Carina Martin; Forrestel, Amy et al. (2016) Accuracy of Clinical Suspicion and Pathologic Diagnosis of Kaposi Sarcoma in East Africa. J Acquir Immune Defic Syndr 71:295-301
Nakalembe, Miriam; Mutyaba, Twaha; Mirembe, Florence (2016) Acceptability of study procedures (self-collected introital swabs, blood draws and stool sample collection) by students 10-16 years for an HPV vaccine effectiveness study: a pilot study. BMC Res Notes 9:170
Semeere, Aggrey; Wenger, Megan; Busakhala, Naftali et al. (2016) A prospective ascertainment of cancer incidence in sub-Saharan Africa: The case of Kaposi sarcoma. Cancer Med 5:914-28
Huchko, Megan J; Maloba, May; Nakalembe, Miriam et al. (2015) The time has come to make cervical cancer prevention an essential part of comprehensive sexual and reproductive health services for HIV-positive women in low-income countries. J Int AIDS Soc 18:20282
Freeman, Esther; Semeere, Aggrey; Wenger, Megan et al. (2015) Pitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi's sarcoma in five countries across sub-Saharan Africa. BMC Cancer 16:65
Tjiam, M Christian; Taylor, James P A; Morshidi, Mazmah A et al. (2015) Viremic HIV Controllers Exhibit High Plasmacytoid Dendritic Cell-Reactive Opsonophagocytic IgG Antibody Responses against HIV-1 p24 Associated with Greater Antibody Isotype Diversification. J Immunol 194:5320-8
Laker-Oketta, Miriam O; Wenger, Megan; Semeere, Aggrey et al. (2015) Task Shifting and Skin Punch for the Histologic Diagnosis of Kaposi's Sarcoma in Sub-Saharan Africa: A Public Health Solution to a Public Health Problem. Oncology 89:60-5
Forrestel, A K; Naujokas, A; Martin, J N et al. (2015) Bacillary angiomatosis masquerading as Kaposi's sarcoma in East Africa. J Int Assoc Provid AIDS Care 14:21-5
McKnight, Tracy R; Yoshihara, Hikari A I; Sitole, Lungile J et al. (2014) A combined chemometric and quantitative NMR analysis of HIV/AIDS serum discloses metabolic alterations associated with disease status. Mol Biosyst 10:2889-97